Under the current medical conditions, traditional treatments such as surgery, radiotherapy and chemotherapy can still play a considerable role in most cancers. However, these three traditional methods also reveal some shortcomings that cannot be ignored: incompleteness, easy transfer and great side effects. In recent years, with the efforts of biologists and oncology experts, DC-CIK biological immunotherapy has entered people's anti-cancer vision, which is complementary to the three traditional treatment methods and is playing a firm anti-cancer role, creating a new road for saving the lives of cancer patients.
DC-CIK biological immunotherapy is a truly individualized treatment, so it can take effect quickly, and it can treat its own diseases with its own cells without rejection. Clinically, it also has a prominent reversal effect on early tumor patients, showing the great power of DC-CIK biological immunotherapy, and can kill the residual tumor cells and tiny tumor cells after operation, so it can effectively prevent the metastasis and recurrence of tumor cells.
A 3A Hospital —— Cancer Biological Center of Beijing 304 Hospital
Oncologists-Gong and Hou Peng
Authoritative therapy -DC-CIK biological immunotherapy